Stockreport

Rhythm Pharma Higher After FDA Approves Supplemental NDA [MarketWatch]

Rhythm Pharmaceuticals, Inc.  (RYTM) 
Last rhythm pharmaceuticals, inc. earnings: 3/8 08:12 am Check Earnings Report
US:NASDAQ Investor Relations: ir.rhythmtx.com
PDF The commercial-stage biopharmaceutical company after the bell Thursday said the U.S. Food and Drug Administration approved the supplemental new drug application for Imc [Read more]